who is the seller/s, page-12

re: more good arixtra news An interesting line in the Intersuisse report is "In the anti-coagulation therapeutic market, the drivers to success are chiefly strong marketing and distribution, followed by publication of the clinical benefits of the drug over competitive products......"

Well nobody is better at the first bit in the US as APP & Arixtra is getting constant good reviews & study data.

Also mentions how Arixtra hasn't improved in sales. Last half of 2005 sales were up 150% on the previous half in the US, although that was from a low base.